Suppr超能文献

用于蛋白质组学应用的新型血液采集与运输装置的设计与表征

Design and Characterization of a Novel Blood Collection and Transportation Device for Proteomic Applications.

作者信息

Kaiser Nathan K, Steers Maximillian, Nichols Charles M, Mellert Hestia, Pestano Gary A

机构信息

Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.

出版信息

Diagnostics (Basel). 2020 Dec 2;10(12):1032. doi: 10.3390/diagnostics10121032.

Abstract

A major hurdle for blood-based proteomic diagnostics is efficient transport of specimens from the collection site to the testing laboratory. Dried blood spots have shown utility for diagnostic applications, specifically those where red blood cell hemolysis and contamination of specimens with hemoglobin is not confounding. Conversely, applications that are sensitive to the presence of the hemoglobin subunits require blood separation, which relies on centrifugation to collect plasma/serum, and then cold-chain custody during shipping. All these factors introduce complexities and potentially increased costs. Here we report on a novel whole blood-collection device (BCD) that efficiently separates the liquid from cellular components, minimizes hemolysis in the plasma fraction, and maintains protein integrity during ambient transport. The simplicity of the design makes the device ideal for field use. Whole blood is acquired through venipuncture and applied to the device with an exact volume pipette. The BCD design was based on lateral-flow principles in which whole blood was applied to a defined area, allowing two minutes for blood absorption into the separation membrane, then closed for shipment. The diagnostic utility of the device was further demonstrated with shipments from multiple sites (n = 33) across the U.S. sent to two different centralized laboratories for analyses using liquid chromatography/mass spectrometry (LC/MS/MS) and matrix assisted laser desorption/ionization-time of flight (MALDI-ToF) commercial assays. Specimens showed high levels of result label concordance for the LC/MS/MS assay (Negative Predictive Value = 98%) and MALDI-ToF assay (100% result concordance). The overall goal of the device is to simplify specimen transport to the laboratory and produce clinical test results equivalent to established collection methods.

摘要

基于血液的蛋白质组学诊断面临的一个主要障碍是将标本从采集地点有效运输到检测实验室。干血斑已显示出在诊断应用中的效用,特别是对于那些红细胞溶血和标本被血红蛋白污染不造成干扰的应用。相反,对血红蛋白亚基存在敏感的应用需要进行血液分离,这依赖于离心来收集血浆/血清,然后在运输过程中进行冷链保存。所有这些因素都带来了复杂性并可能增加成本。在此,我们报告一种新型全血采集装置(BCD),它能有效地将液体与细胞成分分离,使血浆部分的溶血最小化,并在常温运输过程中保持蛋白质完整性。该装置设计简单,非常适合现场使用。通过静脉穿刺采集全血,并用精确体积移液器将其应用于该装置。BCD的设计基于侧向流动原理,即将全血应用于一个特定区域,让血液吸收两分钟进入分离膜,然后封闭用于运输。该装置的诊断效用通过从美国多个地点(n = 33)运往两个不同的中央实验室进行分析得到进一步证明,分析使用液相色谱/质谱联用(LC/MS/MS)和基质辅助激光解吸/电离飞行时间(MALDI-ToF)商业检测方法。对于LC/MS/MS检测(阴性预测值 = 98%)和MALDI-ToF检测(结果一致性为100%),标本显示出高水平结果标签一致性。该装置的总体目标是简化标本运输到实验室的过程,并产生与既定采集方法相当的临床检测结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11dd/7761483/b16d2fd9ff28/diagnostics-10-01032-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验